The decision marks a shift in supply chain resiliency and domestic manufacturing powers, according to the FDA.
“Today, our national capacity for production of these devices is stronger and our supply chain is more resilient because of these collective efforts on behalf of the dedicated people working to save lives,” Suzanne Schwartz, MD, director of the FDA’s Office of Strategic Partnerships and Technology Innovation, said in an Aug. 26 statement.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.